AU1272788A - Use of metformin in the preparation of medicines - Google Patents

Use of metformin in the preparation of medicines

Info

Publication number
AU1272788A
AU1272788A AU12727/88A AU1272788A AU1272788A AU 1272788 A AU1272788 A AU 1272788A AU 12727/88 A AU12727/88 A AU 12727/88A AU 1272788 A AU1272788 A AU 1272788A AU 1272788 A AU1272788 A AU 1272788A
Authority
AU
Australia
Prior art keywords
preparation
metformin
medicines
medicaments
neovascularisation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU12727/88A
Other versions
AU610134B2 (en
Inventor
Marcel Grand
Nicolas Wiernsperger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
LIPHA Liyonnaise Industrielle Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS, LIPHA Liyonnaise Industrielle Pharmaceutique filed Critical LIPHA SAS
Publication of AU1272788A publication Critical patent/AU1272788A/en
Application granted granted Critical
Publication of AU610134B2 publication Critical patent/AU610134B2/en
Assigned to LIPHA, LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE reassignment LIPHA Alteration of Name(s) in Register under S187 Assignors: LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to the use of metformin and its salts in the preparation of medicaments. This derivative is used in the preparation of medicaments manifesting anti-ischaemic and antianoxic properties. It is also employed in the preparation of medicaments intended for the treatment or regression of neovascularisation.
AU12727/88A 1987-03-06 1988-03-04 Use of metformin in the preparation of medicines Ceased AU610134B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8703028 1987-03-06
FR8703028A FR2611500B1 (en) 1987-03-06 1987-03-06 USE OF BIGUANIDE DERIVATIVES IN THE PREPARATION OF MEDICINES

Publications (2)

Publication Number Publication Date
AU1272788A true AU1272788A (en) 1988-09-08
AU610134B2 AU610134B2 (en) 1991-05-16

Family

ID=9348653

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12727/88A Ceased AU610134B2 (en) 1987-03-06 1988-03-04 Use of metformin in the preparation of medicines

Country Status (10)

Country Link
EP (1) EP0283369B1 (en)
JP (1) JPH0818978B2 (en)
AT (1) ATE98120T1 (en)
AU (1) AU610134B2 (en)
CA (1) CA1328606C (en)
DE (1) DE3886075T2 (en)
DK (1) DK169713B1 (en)
FR (1) FR2611500B1 (en)
IL (1) IL85627A (en)
ZA (1) ZA881540B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309125B2 (en) 2002-09-20 2012-11-13 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8470368B2 (en) 2002-09-20 2013-06-25 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100919A (en) * 1984-03-19 1992-03-31 The Rockefeller University Biguanides and derivatives thereof as inhibitors of advanced glycosylation of a target protein
US5356913A (en) * 1990-02-09 1994-10-18 The Upjohn Company Use of insulin sensitizing agents to treat hypertension
CA2071629C (en) * 1990-02-09 1997-12-30 Jerry R. Colca Use of insulin sensitizing agents to treat hypertension
DE4432757A1 (en) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmaceutical preparation containing metformin and process for its preparation
WO1996008262A1 (en) * 1994-09-15 1996-03-21 Pharmagenesis, Inc. Composition and method for immunotherapy
ATE261935T1 (en) * 1997-12-08 2004-04-15 Bristol Myers Squibb Co NEW METFORMIN SALTS AND METHODS
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
AU3536299A (en) * 1998-04-29 1999-11-16 Sumitomo Pharmaceuticals Company, Limited Oral formulation comprising biguanide and an organic acid
JP4606582B2 (en) * 1998-04-29 2011-01-05 大日本住友製薬株式会社 Biguanide drugs for internal use
ATE306910T1 (en) * 1998-07-30 2005-11-15 Merck Sante Sas TABLET WITH EXTENDED RELEASE IN THE STOMACH
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
FR2796551B1 (en) * 1999-07-23 2003-07-25 Lipha NOVEL METFORMIN SALTS, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2796940B1 (en) * 1999-07-26 2005-04-08 Lipha NOVEL METFORMIN SALTS, PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
FR2809310B1 (en) * 2000-05-26 2004-02-13 Centre Nat Rech Scient USE OF BIGUANIDE DERIVATIVES FOR MANUFACTURING A MEDICINAL PRODUCT HAVING A HEALING EFFECT
WO2002012177A1 (en) * 2000-08-03 2002-02-14 Igor Anatolievich Pomytkin Composition of metformin with succinic acid or salts thereof and method for treating diabetes
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
WO2007038979A1 (en) * 2005-09-22 2007-04-12 Swissco Development Ag Effervescent metformin composition and tablets and granules made therefrom
CN105152983A (en) * 2007-01-29 2015-12-16 韩诺生物制药株式会社 N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
GR1007299B (en) * 2010-03-24 2011-06-06 Uni - Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Αβεε, Original effervescent hydrochloric metformin composition in the form of tablets

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2448448A (en) * 1942-06-08 1948-08-31 Courtaulds Ltd Dyeing of textile fibers containing nitrogen

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309125B2 (en) 2002-09-20 2012-11-13 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8470368B2 (en) 2002-09-20 2013-06-25 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8668931B2 (en) 2002-09-20 2014-03-11 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Also Published As

Publication number Publication date
EP0283369A2 (en) 1988-09-21
ATE98120T1 (en) 1993-12-15
AU610134B2 (en) 1991-05-16
JPS63230628A (en) 1988-09-27
IL85627A0 (en) 1988-08-31
DK169713B1 (en) 1995-01-23
DE3886075D1 (en) 1994-01-20
DE3886075T2 (en) 1994-04-14
DK116788D0 (en) 1988-03-04
CA1328606C (en) 1994-04-19
ZA881540B (en) 1988-08-26
JPH0818978B2 (en) 1996-02-28
FR2611500B1 (en) 1990-05-04
IL85627A (en) 1993-01-14
EP0283369A3 (en) 1989-11-29
FR2611500A1 (en) 1988-09-09
EP0283369B1 (en) 1993-12-08
DK116788A (en) 1988-09-07

Similar Documents

Publication Publication Date Title
AU1272788A (en) Use of metformin in the preparation of medicines
ATE142877T1 (en) MELATONINE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS AND FOR PRE-ANESTHESIA
FI862011A0 (en) THERAPEUTIC NUCLEOSIDER.
NO871549L (en) MEDICINES FOR TREATMENT OF EYE INJURIES.
DE3662041D1 (en) New carboxylic acid derivatives, their manufacturing process, use and medicines containing these compounds
DE3782346D1 (en) USE OF CHINOLONE AND NAPHTHYRIDINE ANTIBIOTICS FOR THE PRODUCTION OF OPHTHALMIC MEDICINAL PRODUCTS.
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
ATE99953T1 (en) COMBINATION ANTIVIRAL MEDICATION.
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
DK0406745T3 (en) Antibiotic GE 2270 factors A1, A2, A3 and H
DE68927055D1 (en) 2 ', 5'-OLIGOADENYLATE DERIVATIVES FOR USE AS A MEDICINAL PRODUCT
ES2108680T3 (en) USE OF THE N-N-BUTYL DERIVATIVE OF DESOXINOJIRIMICINA IN THE MANUFACTURE OF A MEDICINAL PRODUCT.
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
ES2037807T3 (en) MEDICINES CONTAINING IN INTERFERON COMBINATION AND 1-DEOXY-PIPERIDINES, PROCEDURE FOR THEIR MANUFACTURE AND APPLICATION.
NO890261D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDROPYRIDINE DERIVATIVES.
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
IL89057A0 (en) Pharmaceutical compositions for the treatment of ulcers containing quinoline or benzodiazine derivatives
NO881798L (en) PROCEDURE FOR MANUFACTURING AN ANTIASTM PREPARATION.
MY101875A (en) Lankacidin derivatives and production thereof.
IT8919204A0 (en) COMPOSITION FOR THE PREVENTION AND TREATMENT OF PERIODONTOPATTA.
IT8741690A0 (en) DRUG FOR THE PROPHYLAXIS AND TREATMENT OF VAGINAL DISBACTERIOSES.
ITGE910094A0 (en) PRODUCT FOR THE TREATMENT AND PREVENTION OF CANCER AND AIDS
IT8719390A0 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS.

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE, LIPH

Free format text: FORMER OWNER WAS: LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE